83759-54-0 Usage
Uses
Used in Pharmaceutical Industry:
Neo-kyotorphin is used as a potential analgesic agent for the treatment of chronic pain conditions. Its stronger pain-relieving effects compared to kyotorphin make it a promising candidate for pharmaceutical development.
Used in Medical Research:
Neo-kyotorphin is used as a subject of study in medical research to further understand its analgesic properties and explore its potential applications in pain management. This research may lead to the development of new therapeutic strategies for various chronic pain conditions.
Used in Drug Delivery Systems:
Neo-kyotorphin is used as a component in drug delivery systems designed to improve the efficacy and bioavailability of analgesic treatments. By incorporating neo-kyotorphin into these systems, researchers aim to enhance the delivery of pain-relieving medications to the target areas in the body, potentially leading to more effective pain management.
Check Digit Verification of cas no
The CAS Registry Mumber 83759-54-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,7,5 and 9 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 83759-54:
(7*8)+(6*3)+(5*7)+(4*5)+(3*9)+(2*5)+(1*4)=170
170 % 10 = 0
So 83759-54-0 is a valid CAS Registry Number.
InChI:InChI=1/C28H47N9O9/c1-15(39)22(30)26(44)37-21(14-38)25(43)34-18(5-2-3-11-29)23(41)36-20(13-16-7-9-17(40)10-8-16)24(42)35-19(27(45)46)6-4-12-33-28(31)32/h7-10,15,18-22,38-40H,2-6,11-14,29-30H2,1H3,(H,34,43)(H,35,42)(H,36,41)(H,37,44)(H,45,46)(H4,31,32,33)/t15-,18+,19+,20+,21+,22+/m1/s1
83759-54-0Relevant academic research and scientific papers
Diffusion based kinetic selectivity modulation of enzymatic proteolysis in a microfluidic reactor: Experimental analysis and stochastic modeling
Elagli, Adil,Laurette, Simon,Treizebre, Anthony,Bocquet, Bertrand,Froidevaux, Renato
, p. 3873 - 3882 (2014/01/06)
Microreactors enable new experimental ways for enzyme engineering. In this context, we show that the liquid-liquid parallel laminar flows in microchannels cause a kinetic selectivity modification of proteolytic enzymatic reaction involving hemoglobin and pepsin, reaction that generates numerous bioactive peptides at different advancement state. Here we show that this diffusion based kinetic modulation induces an altered peptides appearance kinetics for a part of the initial substrate population. Indeed, microfluidic and conventional batch experiments performed in the same reaction conditions lead to strong differences in the resulting peptidic profiles obtained by reversed-phase high-performance liquid chromatography. Such differences are explained by the laminar flow diffusive conditions inside microchannels and are supported by a stochastic algorithm based on the Michaelis-Menten equation. Several bioactive peptides are identified by mass spectrometry and show the potential of such methodology in peptides screening from a complex proteolysis but also for selective peptides preparation by microfluidics.
